Oxidium Technologies LLC is a Wilmington, Delaware-based company specializing in chlorine dioxide disinfection technology. An affiliate of Quip Laboratories, it recently acquired BASF's Aseptrol portfolio in March 2026, encompassing EPA-registered chlorine dioxide formulations originally developed for water purification, disinfection, and dental line cleaning.
Leveraging four decades of family-owned specialty chemical production expertise, Oxidium engineers solutions for microbial control in healthcare, research facilities, veterinary clinics, food operations, industrial water treatment, agriculture, food safety, and emergency response applications. The Aseptrol platform enables on-demand generation of high-purity ClOâ‚‚ via tablets, powders, and sustained-release vapors for surface disinfection, equipment sterilization, and space decontamination.
